Galderma unveils final nine-month data showing lasting efficacy and patient satisfaction with its Injectable Aesthetics portfolio when addressing facial aesthetic changes after medication-driven weight loss Final data from a first-of-its-kind clinical trial confirm that the combination of Sculptra and Restylane Lyft or Contour* delivers sustained improvement in facial aesthetic appearance for patients experiencing facial volume loss due to medication-driven weight loss 1 Following interim analysis at three months presented earlier this year, a six-month extension study was conducted to capture the durability of treatment effects after nine months 1 Galderma continues to lead the response to addressing the aesthetic concerns of patients experiencing medication-driven weight loss, leveraging its deep dermatological expertise and working closely with healthcare professionals to meet evolving patient needs Zug, Switzerland July 17, 2025 Galderma has revealed positive final data from a phase IV first-of-its-kind trial exploring the benefits of Restylane Lyft or Contour in combination with Sculptra to address the aesthetic concerns of patients experiencing facial volume loss associated with medication-driven weight loss
Many patients notice reduced cravings and better portion control within 1 to 2 weeks
Si eres mujer y haces fuerza la L-carnitina puede ayudarte a mantener energa y constancia el promedio es entre 500 a 1,500 mg al da
Liver Health & Metabolic Benefits Evidence suggests a reduced risk of hepatic failure and inflammation
Doctors know this happens to GLP-1 patients, but the cause and scale of the changes is still being investigated
GABA BPC 157/GABA relation goes with the same supportive evidence as in the dopamine, serotonin, and glutamate studies (see Chapters Dopamine, Serotonin, Glutamate), a restorative dimension, as mentioned before [1]
